CVS is rated highest in shareholder yield investor model, meets strategy's tests, strong interest indicated.

From Nasdaq: 2025-03-15 11:54:33

Validea’s guru fundamental report for CVS HEALTH CORP (CVS) shows it rates highest using the Shareholder Yield Investor model. The strategy looks for companies returning cash to shareholders through dividends, buybacks, and debt paydown. CVS is a large-cap growth stock in the Retail (Drugs) industry, with a rating of 80% based on fundamentals and valuation. The stock meets most of the strategy’s tests, with a strong interest indicated. Meb Faber, founder of Cambria Investments, focuses on shareholder yield and creating value for shareholders. Validea offers stock analysis and model portfolios based on investment legends.



Read more at Nasdaq: CVS Quantitative Stock Analysis | Nasdaq